NCT01467726View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Alzheimer's Disease

Interventions

DRUG

Velusetrag

Capsules

DRUG

Velusetrag

Capsules

DRUG

Placebo

Capsules

Trial Locations (1)

33025

Comprehensive Clinical Development, Miramar

Sponsors

Lead Sponsor

Alfasigma S.p.A.

Collaborators (1)

Theravance Biopharma

All Listed Sponsors

collaborator

Theravance Biopharma

INDUSTRY

lead

Alfasigma S.p.A.

INDUSTRY